| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0073 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |